2026 Sergio A. Jimenez: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	106	1145	1020	681	595	436	45222
Medicine	105	6727	6325	3550	3294	435	44455

Overview

Sergio A. Jimenez is affiliated with Thomas Jefferson University in the United States. Their research primarily focuses on systemic sclerosis and related diseases, contributing a significant number of publications across various fields of medicine and molecular biology.

The scientist's work covers interdisciplinary fields including:

Medicine
Biochemistry, Genetics and Molecular Biology

Key subfields of their research involve:

Pathology and Forensic Medicine
Molecular Biology
Pulmonary and Respiratory Medicine
Dermatology
Artificial Intelligence

The main topics explored in their publications include:

Systemic Sclerosis and Related Diseases
Dermatologic Treatments and Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Inflammatory Myopathies and Dermatomyositis
Extracellular vesicles in disease
Eosinophilic Disorders and Syndromes
TGF-β signaling in diseases

Among the frequently published venues for their research are:

Clinical and Experimental Rheumatology
Lara D. Veeken
Journal of Clinical Medicine
Annals of the Rheumatic Diseases
Translational research

Notable recent papers authored or co-authored by Sergio A. Jimenez include:

Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH (2020, Annals of the Rheumatic Diseases)
Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target (2021, Journal of Clinical Medicine)
Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition (2021, Translational research)
Increased expression of interferon regulated and antiviral response genes in CD31+/CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease (2021, Clinical and Experimental Rheumatology)
Serine/threonine kinase inhibition as antifibrotic therapy: transforming growth factor-β and Rho kinase inhibitors (2021, Lara D. Veeken)

Sergio A. Jimenez collaborates frequently with several co-authors including:

Sonsoles Piera-Velázquez
Fabian A. Mendoza
Giuseppina Abignano
Heidi M. Hermes
Francesco Del Galdo

Best Publications

2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

9175
Citations
Osteoarthritis cartilage histopathology: grading and staging

K P H Pritzker;K P H Pritzker;S A Jimenez;K Ostergaard

2643
Citations
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis

J.A. Roman-Blas;S.A. Jimenez

858
Citations
Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts.

J Varga;J Rosenbloom;S A Jimenez

827
Citations
Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic Disorders

Sonsoles Piera-Velazquez;Zhaodong Li;Sergio A. Jimenez

703
Citations
Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.

Artlett Cm;Smith Jb;Jimenez Sa

588
Citations
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs

Eric Londina;Phillipe Lohera;Aristeidis G. Telonis;Kevin Quann

526
Citations
A disease severity scale for systemic sclerosis: development and testing.

T A Medsger;A J Silman;V D Steen;C M Black

520
Citations
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study

Fredrick M. Wigley;Robert A. Wise;James R. Seibold;Deborah A. McCloskey

508
Citations
Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Sonsoles Piera-Velazquez;Sergio A. Jimenez

467
Citations
Selective inhibition of human diploid fibroblast collagen synthesis by interferons.

S A Jimenez;B Freundlich;J Rosenbloom

459
Citations
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

Sergio A. Jimenez;Chris T. Derk

430
Citations
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

Peter A. Merkel;Peter A. Merkel;Karen Herlyn;Richard W. Martin;Jennifer J. Anderson

413
Citations
A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.

Linda D. Siracusa;Rodney McGrath;Qing Ma;John J. Moskow

408
Citations
Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy).

Nilofer Nina Ahmad;Leena Ala-Kokko;Robert G. Knowlton;Sergio A. Jimenez

383
Citations
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

Alain H. Rook;Bruce Freundlich;Brian V. Jegasothy;Maritza I. Perez

364
Citations
Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature

Fabian A. Mendoza;Carol M. Artlett;Nora Sandorfi;Kevin Latinis

329
Citations
Hydroxyproline content determines the denaturation temperature of chick tendon collagen.

Joel Rosenbloom;Margaret Harsch;Sergio Jimenez

316
Citations
The gastrointestinal manifestations of scleroderma: pathogenesis and management

Sidney Cohen;Igor Laufer;William J. Snape;Yih-Fu Shiau

313
Citations
Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies

Joel Rosenbloom;Susan V. Castro;Sergio A. Jimenez

298
Citations